Información para la
Vigilancia y Control
del Cáncer
Recursos y formación
RCG Noticia

Immunotherapy could help tackle tough liver cancer
12/04/2014
Research
The liver cancer (Hepatocellular Carcinoma (HCC)) may be treated by adoptive T- cell theray. This new therapeutic approach in the treatment of HCC could be very important as without treatment the 5 year survival rate is just 5%. Globally, HCC accounts for 746,000 deaths, and in the UK alone is responsible for over 4,000 deaths per year.
 
Enlaces relacionados:
 
 
Permalink: http://cancergranada.com/?iid=immunotherapy_liver_cancer&itid=4&lan=es
 
© Desarrollado por Web4bio